Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 8/20 | 0.49 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.34 |
| ▸ | CCKAR | P32238 | 6/20 | 0.33 |
| ▸ | CCKBR | P32239 | 6/20 | 0.33 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.33 |
| ▸ | SIRT2 | Q8IXJ6 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30407756 | 1.00 | GLP1R (0.49) | GLP1RGLO1PTPN1CCKARCCKBR | |
| SCHEMBL30407384 | 1.00 | GLP1R (0.49) | GLP1RGLO1PTPN1CCKARCCKBR | |
| SCHEMBL29467601 | 1.00 | GLP1R (0.49) | GLP1RGLO1PTPN1CCKARCCKBR | |
| SCHEMBL30407109 | 0.98 | GLP1R (0.51) | GLP1RGLO1PTPN1CCKARCCKBR | |
| SCHEMBL30407395 | 0.98 | GLP1R (0.51) | GLP1RGLO1PTPN1CCKARCCKBR | |
| SCHEMBL30407255 | 0.97 | GLP1R (0.52) | GLP1RGLO1PTPN1ROCK2SIRT2 | |
| SCHEMBL30407104 | 0.92 | GLP1R (0.46) | GLP1RCCKARCCKBRROCK2 | |
| SCHEMBL30408018 | 0.91 | GLP1R (0.43) | GLP1R | |
| SCHEMBL30407645 | 0.91 | GLP1R (0.43) | GLP1R | |
| SCHEMBL30407264 | 0.91 | GLP1R (0.43) | GLP1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4426741-A1 | BCMA MONOCLONAL ANTIBODY AND THE ANTIBODY-DRUG CONJUGATE | Hangzhou DAC Biotech Co., Ltd. (CN) | 2024-09-11 | — | — | EP | disclosed |
| EP-4426729-A1 | SPECIFIC CONJUGATION FOR AN ANTIBODY-DRUG CONJUGATE | Hangzhou Dac Biotech Co., Ltd. (CN) | 2024-09-11 | — | — | EP | disclosed |
| WO-2023078021-A1 | BCMA MONOCLONAL ANTIBODY AND THE ANTIBODY-DRUG CONJUGATE | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2023-05-11 | — | — | WO | disclosed |
| WO-2023078273-A1 | SPECIFIC CONJUGATION FOR AN ANTIBODY-DRUG CONJUGATE | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2023-05-11 | — | — | WO | disclosed |